Issues at Novo Nordisk lead to shortage of fast-acting diabetes drug

The Danish Medicines Agency has reported that it is currently difficult to find diabetes drug Novorapid in Denmark.
Photo: Jacob Ehrbahn/Politiken
Photo: Jacob Ehrbahn/Politiken
by christian bundgaard, translated by catherine brett

There is a current shortage of Novo Nordisk’s fast-acting diabetes drug Novorapid 100 E/ml in Denmark, the Danish Medicines Agency has announced.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading